141 related articles for article (PubMed ID: 24614577)
1. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.
Zhang H; Mi J; Huo Y; Huang X; Xing J; Yamamoto A; Gao Y
Int J Pharm; 2014 May; 466(1-2):156-62. PubMed ID: 24614577
[TBL] [Abstract][Full Text] [Related]
2. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
3. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
5. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
6. Absorption-improving effects of chitosan oligomers based on their mucoadhesive properties: a comparative study on the oral and pulmonary delivery of calcitonin.
Zhang H; Huang X; Sun Y; Xing J; Yamamoto A; Gao Y
Drug Deliv; 2016 Sep; 23(7):2419-2427. PubMed ID: 25594571
[TBL] [Abstract][Full Text] [Related]
7. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
8. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
9. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer.
Rama Prasad YV; Minamimoto T; Yoshikawa Y; Shibata N; Mori S; Matsuura A; Takada K
Int J Pharm; 2004 Mar; 271(1-2):225-32. PubMed ID: 15129989
[TBL] [Abstract][Full Text] [Related]
10. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of low molecular weight heparin in animals and human subjects.
Nissan A; Ziv E; Kidron M; Bar-On H; Friedman G; Hyam E; Eldor A
Haemostasis; 2000; 30(5):225-32. PubMed ID: 11251329
[TBL] [Abstract][Full Text] [Related]
13. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.
Yang T; Hussain A; Bai S; Khalil IA; Harashima H; Ahsan F
J Control Release; 2006 Oct; 115(3):289-97. PubMed ID: 17023085
[TBL] [Abstract][Full Text] [Related]
14. Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of interferon-alpha in rats.
Yamada K; Odomi M; Okada N; Fujita T; Yamamoto A
J Pharm Sci; 2005 Nov; 94(11):2432-40. PubMed ID: 16200616
[TBL] [Abstract][Full Text] [Related]
15. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Thanou M; Nihot MT; Jansen M; Verhoef JC; Junginger HE
J Pharm Sci; 2001 Jan; 90(1):38-46. PubMed ID: 11064377
[TBL] [Abstract][Full Text] [Related]
16. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.
Kim SK; Lee EH; Vaishali B; Lee S; Lee YK; Kim CY; Moon HT; Byun Y
J Control Release; 2005 Jun; 105(1-2):32-42. PubMed ID: 15925422
[TBL] [Abstract][Full Text] [Related]
17. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
18. Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats.
Mori S; Matsuura A; Rama Prasad YV; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):418-21. PubMed ID: 14993814
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
20. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]